162 related articles for article (PubMed ID: 21193424)
21. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for mortality in patients with bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa: clinical impact of bacterial virulence and strains on outcome.
Jeong SJ; Yoon SS; Bae IK; Jeong SH; Kim JM; Lee K
Diagn Microbiol Infect Dis; 2014 Oct; 80(2):130-5. PubMed ID: 25112900
[TBL] [Abstract][Full Text] [Related]
23. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.
Recio R; Mancheño M; Viedma E; Villa J; Orellana MÁ; Lora-Tamayo J; Chaves F
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767719
[TBL] [Abstract][Full Text] [Related]
24. Pseudomonas aeruginosa bacteremia after burn injury: the impact of multiple-drug resistance.
Theodorou P; Thamm OC; Perbix W; Phan VT
J Burn Care Res; 2013; 34(6):649-58. PubMed ID: 23817000
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections.
Tschudin-Sutter S; Fosse N; Frei R; Widmer AF
PLoS One; 2018; 13(9):e0203295. PubMed ID: 30235247
[TBL] [Abstract][Full Text] [Related]
26. A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
Sun HY; Shields RK; Cacciarelli TV; Muder RR; Singh N
Transpl Infect Dis; 2010 Dec; 12(6):555-60. PubMed ID: 20626709
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
Tuon FF; Gortz LW; Rocha JL
Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
[TBL] [Abstract][Full Text] [Related]
28. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study.
Vuotto F; Berthon C; Lemaitre N; Duhamel A; Balkaran S; Le Ray E; Micol JB; Faure K; Alfandari S
Am J Infect Control; 2013 Jun; 41(6):527-30. PubMed ID: 23219670
[TBL] [Abstract][Full Text] [Related]
29. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.
Micek ST; Lloyd AE; Ritchie DJ; Reichley RM; Fraser VJ; Kollef MH
Antimicrob Agents Chemother; 2005 Apr; 49(4):1306-11. PubMed ID: 15793102
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of septic shock in patients with hematologic malignancies and Pseudomonas infections.
Jeddi R; Ghédira H; Ben Amor R; Turki A; Kacem K; Ben Abdennebi Y; Ben Lakhal R; Aissaoui L; Ben Abid H; Bel Hadjali Z; Meddeb B
Hematology; 2011 May; 16(3):160-5. PubMed ID: 21669056
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa.
Ferreira ML; Dantas RC; Faria ALS; Gonçalves IR; Silveira de Brito C; Queiroz LL; Gontijo-Filho PP; Ribas RM
J Med Microbiol; 2015 Mar; 64(Pt 3):262-271. PubMed ID: 25596115
[TBL] [Abstract][Full Text] [Related]
32. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology.
Tacconelli E; Tumbarello M; Bertagnolio S; Citton R; Spanu T; Fadda G; Cauda R
Emerg Infect Dis; 2002 Feb; 8(2):220-1. PubMed ID: 11897080
[No Abstract] [Full Text] [Related]
33. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan.
Leung CH; Wang NY; Liu CP; Weng LC; Hsieh FC; Lee CM
J Microbiol Immunol Infect; 2008 Dec; 41(6):491-8. PubMed ID: 19255693
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of appropriate empiric combination versus monotherapy for Pseudomonas aeruginosa bacteremia.
Bowers DR; Liew YX; Lye DC; Kwa AL; Hsu LY; Tam VH
Antimicrob Agents Chemother; 2013 Mar; 57(3):1270-4. PubMed ID: 23263001
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of colistin in the treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in patients with hematologic malignancy: a matched pair analysis.
Durakovic N; Radojcic V; Boban A; Mrsic M; Sertic D; Serventi-Seiwerth R; Nemet D; Labar B
Intern Med; 2011; 50(9):1009-13. PubMed ID: 21532223
[TBL] [Abstract][Full Text] [Related]
37. Impact of Pseudomonas aeruginosa bacteraemia in a tertiary hospital: Mortality and prognostic factors.
Callejas-Díaz A; Fernández-Pérez C; Ramos-Martínez A; Múñez-Rubio E; Sánchez-Romero I; Vargas Núñez JA
Med Clin (Barc); 2019 Feb; 152(3):83-89. PubMed ID: 29885868
[TBL] [Abstract][Full Text] [Related]
38. Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.
Zhang Y; Chen XL; Huang AW; Liu SL; Liu WJ; Zhang N; Lu XZ
Emerg Microbes Infect; 2016 Mar; 5(3):e27. PubMed ID: 27004762
[TBL] [Abstract][Full Text] [Related]
39. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas aeruginosa bacteremia in children.
Koprnova J; Korcova J; Gogova M; Krcmery V
Eur J Epidemiol; 2004; 19(5):499-500. PubMed ID: 15233326
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
